ARCHIVES

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

This article is from The Cancer Letter archive.

Vol. 10 No. 22 | June 1, 1984

Download PDF Visit The Full Archive

Related Articles

Perot Systems To Provide IT Support For US Oncology Enterprise Applications.

December 15, 2000

NCI CTEP Approved Trials For the Month of April

April 26, 2013

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

Robert Young To Step Down As Fox Chase Cancer Center President in 2007.

September 29, 2006

Sieber Direct Communications At NCI, Reorganizing Offices.

March 31, 2000

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

February 14, 2014